title: Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic mice.
authors.affiliation: Discovery Research, GlaxoSmithKline, King of Prussia, PA, USA. mkhansen99@yahoo.com
authors.forename: Michael K
authors.initials: MK
authors.lastname: Hansen
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: McVey
authors.forename: Ray F
authors.initials: RF
authors.lastname: White
authors.forename: Jeffrey J
authors.initials: JJ
authors.lastname: Legos
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Brusq
authors.forename: Didier A
authors.initials: DA
authors.lastname: Grillot
authors.forename: Marc
authors.initials: M
authors.lastname: Issandou
authors.forename: Frank C
authors.initials: FC
authors.lastname: Barone